An exploration of the AI companies in healthcare, the drug price debate and the latest twist in the Trump Administration’s allegation that Tylenol is linked to autism were the hot topics on the latest episode of the Debunked Podcast hosted by Arundhati Parmar, editor in chief of MedCity News, and Samir Batra, managing partner of Health Innovation Pitch.

Part of the conversation focused on TrumpRx , a platform the Trump administration announced this summer that is designed to reduce drug prices for Americans. So far, two drug makers have committed to support TrumpRx. Pfizer was the first and published an announcement at the end of September.

“Pfizer has voluntarily agreed to implement measures designed to ensure Americans receive comparable drug prices to those available in other develo

See Full Page